Akero Therapeutics, Inc.盘中异动股价大跌5.25%报42.56美元

市场透视2025-05-07

北京时间2025年05月07日00时44分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价急速下跌5.25%。截至发稿，该股报42.56美元/股，成交量25.8663万股，换手率0.32%，振幅4.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.42倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533124657?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-07 00:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2533124657","market":"us","top_or_hot":-1,"title":"Akero Therapeutics, Inc.盘中异动 股价大跌5.25%报42.56美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月07日00时44分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价急速下跌5.25%。截至发稿，该股报42.56美元/股，成交量25.8663万股，换手率0.32%，振幅4.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.42倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700445794ee3207&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akero Therapeutics, Inc.盘中异动 股价大跌5.25%报42.56美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkero Therapeutics, Inc.盘中异动 股价大跌5.25%报42.56美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-07 00:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700445794ee3207&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月07日00时44分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价急速下跌5.25%。截至发稿，该股报42.56美元/股，成交量25.8663万股，换手率0.32%，振幅4.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.42倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700445794ee3207&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700445794ee3207&s=b","article_id":"2533124657","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700445794ee3207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2533124657","pubTimestamp":1746549897,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月07日00时44分，Akero Therapeutics, Inc.股票出现异动，股价急速下跌5.25%。Akero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为5.33%。Akero Therapeutics, Inc.公司简介：Akero Therapeutics Inc是一家临床阶段的生物技术公司，致力于开发和商业化针对医疗需求高度未得到满足的严重代谢疾病的变革性治疗。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","AKRO":"Akero Therapeutics","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Akero Therapeutics, Inc. shares fell 5.25% to $42.56 during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"AKRO":1},"content_text":"北京时间2025年05月07日00时44分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价急速下跌5.25%。截至发稿，该股报42.56美元/股，成交量25.8663万股，换手率0.32%，振幅4.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.42倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Akero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为5.33%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 (To Pur Com)、Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Sol-Gel Technologies Ltd.涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为7924.72%、1200.43%、500.22%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 (To Pur Com)、Polyrizon Ltd.，振幅分别为158.45%、42.31%、40.65%。Akero Therapeutics, Inc.公司简介：Akero Therapeutics Inc是一家临床阶段的生物技术公司，致力于开发和商业化针对医疗需求高度未得到满足的严重代谢疾病的变革性治疗。它专注于非酒精性脂肪性肝炎(NASH)，一种没有任何批准疗法的疾病。该公司的候选产品efruxifermin是一种FGF21类似物，其特性有可能解决非酒精性脂肪性肝炎(NASH)发病机制的核心过程。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533124657","isCrawlerRequest":true}

Akero Therapeutics, Inc.盘中异动 股价大跌5.25%报42.56美元

精彩评论

Akero Therapeutics, Inc.盘中异动股价大跌5.25%报42.56美元